Defining the Optimum Parameters for Efficient Size Separations of Proteins

Importance of the Topic

Size exclusion chromatography (SEC) of proteins provides essential information on molecular weight, aggregation, and fragmentation that supports applications from early-stage drug discovery to quality control of final biopharmaceutical products.

Aim and Overview of the Study

This study evaluated key SEC parameters—stationary phase chemistry, particle size, and salt concentration—to establish optimal conditions for high-resolution separations of a range of protein standards including antibodies and small globular proteins.

Methodology and Instrumentation

SEC experiments were performed using three columns and two UHPLC systems under controlled conditions:

• Columns: Agilent Bio SEC-3 (300 Å, 4.6×300 mm, 3 µm), Vendor A (4.6×300 mm, 1.7 µm), Vendor B (4.6×300 mm, 4 µm)
• Instruments: Agilent 1290 Infinity UHPLC, Agilent 1260 Infinity UHPLC
• Eluents: 150 mM phosphate buffer pH 7 (A) and 20 mM phosphate with 25–500 mM NaCl pH 7 (B)
• Flow rate: 0.35 mL/min; Detection: UV at 220 nm
• Samples: Bio-Rad gel filtration standard mix, lysozyme, α-chymotrypsinogen A, ovalbumin, myoglobin, polyclonal mouse IgG

Main Results and Discussion

All columns exhibited ionic interactions at low salt levels, shown by lysozyme retention. Vendor A also displayed hydrophobic interactions at high salt, causing peak broadening. The Agilent Bio SEC-3 column maintained minimal non-specific interactions across 25–500 mM NaCl, delivering consistent peak shapes and high resolution.

After extensive salt-dependence testing, Vendor A suffered reduced efficiency—attributed to column fouling—partially recoverable by recommended washes. Smaller particle sizes generally yielded higher plate counts, but only the Bio SEC-3 chemistry produced the clearest fragmentation pattern for mouse IgG, resolving monomer, dimer, and degradation fragments.

Benefits and Practical Applications

• High-throughput drug discovery assays requiring rapid and reproducible size separations
• Process monitoring during biomanufacturing to detect early aggregation events
• Final product QA/QC demanding accurate quantitation of monomer and fragment levels
• Extended column lifetime due to reduced non-specific adsorption and fouling

Future Trends and Opportunities

Advances in stationary phase designs aim to further suppress secondary interactions. Integration of SEC with mass spectrometry offers deeper molecular characterization. Miniaturized and high-throughput SEC formats will increase sample throughput. AI-driven method optimization may streamline parameter selection for diverse protein analytes.

Conclusion

Stationary phase chemistry and particle size critically influence non-specific ionic and hydrophobic interactions in protein SEC. Eluent composition must be tailored to column properties and protein characteristics to ensure high resolution, robust performance, and prolonged column life.

Instrumentation Used

• Agilent 1290 Infinity UHPLC
• Agilent 1260 Infinity UHPLC
• Agilent Bio SEC-3 column, 300 Å, 4.6×300 mm, 3 µm
• Vendor A column, 4.6×300 mm, 1.7 µm
• Vendor B column, 4.6×300 mm, 4 µm

References

• No external literature citations provided in the original application note.